acetylcarnitine has been researched along with HIV Lipodystrophy Syndrome in 3 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "L-carnitine is a nonessential micronutrient that regulates fatty acid transport into the mitochondrial matrix for metabolism via beta-oxidation." | 2.42 | Acetyl-L-carnitine for the treatment of HIV lipoatrophy. ( Day, L; Gerschenson, M; Shikuma, C, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedini, S | 1 |
| Perseghin, G | 1 |
| Terruzzi, I | 1 |
| Scifo, P | 1 |
| Invernizzi, PL | 1 |
| Del Maschio, A | 1 |
| Lazzarin, A | 1 |
| Luzi, L | 1 |
| Milazzo, L | 1 |
| Menzaghi, B | 1 |
| Caramma, I | 1 |
| Nasi, M | 1 |
| Sangaletti, O | 1 |
| Cesari, M | 1 |
| Zanone Poma, B | 1 |
| Cossarizza, A | 1 |
| Antinori, S | 1 |
| Galli, M | 1 |
| Day, L | 1 |
| Shikuma, C | 1 |
| Gerschenson, M | 1 |
1 review available for acetylcarnitine and HIV Lipodystrophy Syndrome
| Article | Year |
|---|---|
Acetyl-L-carnitine for the treatment of HIV lipoatrophy.
Topics: Acetylcarnitine; Carnitine; Fatty Acids; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Huma | 2004 |
2 trials available for acetylcarnitine and HIV Lipodystrophy Syndrome
| Article | Year |
|---|---|
Effect of L-acetylcarnitine on body composition in HIV-related lipodystrophy.
Topics: Acetylcarnitine; Adult; Blood Glucose; Body Composition; Case-Control Studies; Female; HIV-Associate | 2009 |
Effect of antioxidants on mitochondrial function in HIV-1-related lipoatrophy: a pilot study.
Topics: Absorptiometry, Photon; Acetylcarnitine; Adult; Antioxidants; Body Composition; Breath Tests; Carboh | 2010 |